Galenica
Financials
Estimates*
| CHF | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.5b | 3.8b | 4.0b | 3.7b | 3.9b | 4.1b | 4.2b |
| % growth | 5 % | 10 % | 5 % | (7 %) | 4 % | 4 % | 4 % |
| EBITDA | 310m | 297m | 304m | 297m | 280m | 310m | 317m |
| % EBITDA margin | 9 % | 8 % | 8 % | 8 % | 7 % | 8 % | 8 % |
| Profit | 172m | 168m | 165m | 285m | 168m | 181m | 189m |
| % profit margin | 5 % | 4 % | 4 % | 8 % | 4 % | 4 % | 4 % |
| EV / revenue | 1.0x | 1.0x | 1.1x | 1.1x | 1.1x | 1.0x | 1.0x |
| EV / EBITDA | 11.3x | 13.1x | 14.3x | 14.4x | 15.3x | 13.6x | 13.3x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Galenica
EditGalenica is a prominent healthcare provider in Switzerland, known for its comprehensive services that span across logistics, IT solutions, and retail. The company operates in the Swiss healthcare market, serving a diverse range of clients including pharmacies, drugstores, and healthcare professionals. Galenica's business model is built on providing integrated solutions that streamline operations for its clients, enhancing efficiency and service quality. The company generates revenue through its various business segments, including Retail, Products & Brands, and Services. The Retail segment focuses on health and beauty products, while the Products & Brands segment develops and markets proprietary brands. The Services segment offers logistics and IT solutions to healthcare providers, ensuring seamless supply chain management and operational support. Galenica's market presence is bolstered by its commitment to innovation and sustainability, aiming to improve patient safety and health outcomes. The company is publicly traded, providing transparency and accountability to its stakeholders.
Keywords: healthcare, logistics, IT solutions, retail, health, beauty, Switzerland, pharmacies, drugstores, innovation.
